LIVN Q1 2022 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$240M-3.0% YoY

Gross Profit

$168M70.1% margin

Operating Income

$10M4.0% margin

Net Income

$3M1.2% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

-11.1%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$21M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$1.1B

Stockholders' Equity

$1.3B

Cash & Equivalents

$442M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$240M	$248M	-3.0%
Gross Profit	$168M	$163M	+3.1%
Operating Income	$10M	-$6M	+266.8%
Net Income	$3M	-$31M	+109.7%

Revenue Segments

Cardiopulmonary Segment

$117M49%

Neuromodulation Segment

$110M46%

Advanced Circulatory Support Segment

$12M5%

Geographic Segments

UNITED STATES

$136M57%

Locations Excluding The United States And Europe

$59M24%

Europe

$45M19%